Philips | PHIA - Cash And Equivalent


Philips reported EUR2.79B in Cash and Equivalent for its fiscal quarter ending in December of 2025.





Cash And Equivalent Change Date
ABB USD 3.32B 1.32B Mar/2026
Abbott USD 6.8B 1.72B Mar/2026
Aena EUR 2.05B 1.1B Dec/2025
Alcon AG USD 1.58B 80M Mar/2026
ASM International NV EUR 981.6M 45.2M Mar/2026
ASML Holding EUR 7.97B 4.95B Mar/2026
AstraZeneca USD 7.56B 1.85B Mar/2026
Bayer EUR 6.67B 774M Dec/2025
Boston Scientific USD 1.45B 512M Mar/2026
Demant DKK 1.33B 188M Dec/2025
EDAP TMS EUR 29.84M 4.35M Dec/2024
Edwards Lifesciences USD 2.4B 538M Mar/2026
Essilor EUR 3.54B 758M Dec/2025
Fresenius EUR 1.31B 81M Dec/2025
Fresenius Medical Care EUR 1.24B 343.37M Mar/2026
Geberit CHF 403.6M 4.1M Mar/2025
Getinge SEK 2.96B 720M Dec/2024
GN Store Nord DKK 1.12B 352M Dec/2025
GRIFOLS EUR 801M 242.31M Dec/2025
HeidelbergCement EUR 2.54B 1.21B Dec/2025
Intuitive Surgical USD 7.98B 1.05B Mar/2026
Koninklijke Philips EUR 2.59B 680M Mar/2026
Legrand EUR 2.37B 619.8M Dec/2025
Lonza CHF 719M 188M Dec/2025
Medtronic USD 1.15B 135M Dec/2025
Merck EUR 2.33B 77M Dec/2025
Philips EUR 2.79B 882M Dec/2025
Sanofi EUR 7.66B 1.25B Dec/2025
SAP EUR 10.04B 1.83B Mar/2026
Schneider Electric EUR 4.63B 621M Dec/2025
Trinity Biotech USD 5.14M 3.8M Dec/2025